EA 3452 CITHEFOR, Université de Lorraine, Nancy, France.
BSC UMR7242 "GPCRs, pain and inflammation" team, CNRS, Université de Strasbourg Labex Medalis, Illkirch, France.
Br J Pharmacol. 2019 Jun;176(12):2049-2062. doi: 10.1111/bph.14644. Epub 2019 May 7.
Angiotensin II (AngII) and NO regulate the cerebral circulation. AngII AT receptors exert ligand-dependent and ligand-independent (myogenic tone [MT]) vasoconstriction of cerebral vessels. NO induces post-translational modifications of proteins such as S-nitrosation (redox modification of cysteine residues). In cultured cells, S-nitrosation decreases AngII's affinity for the AT receptor. The present work evaluated the functional consequences of S-nitrosation on both AngII-dependent and AngII-independent cerebrovascular responses.
S-Nitrosation was induced in rat isolated middle cerebral arteries by pretreatment with the NO donors, S-nitrosoglutathione (GSNO) or sodium nitroprusside (SNP). Agonist-dependent activation of AT receptors was evaluated by obtaining concentration-response curves to AngII. Ligand-independent activation of AT receptors was evaluated by calculating MT (active vs. passive diameter) at pressures ranging from 20 to 200 mmHg in the presence or not of a selective AT receptor inverse agonist.
GSNO or SNP completely abolished the AngII-dependent AT receptor-mediated vasoconstriction of cerebral arteries. GSNO had no impact on responses to other vasoconstrictors sharing (phenylephrine, U46619) or not (5-HT) the same signalling pathway. MT was reduced by GSNO, and the addition of losartan did not further decrease MT, suggesting that GSNO blocks AT receptor-dependent MT. Ascorbate (which reduces S-nitrosated compounds) restored the response to AngII but not the soluble GC inhibitor ODQ, suggesting that these effects are mediated by S-nitrosation rather than by S-nitrosylation.
In rat middle cerebral arteries, GSNO pretreatment specifically affects the AT receptor and reduces both AngII-dependent and AngII-independent activation, most likely through AT receptor S-nitrosation.
血管紧张素 II(AngII)和一氧化氮(NO)调节脑循环。AngII AT 受体发挥配体依赖性和配体非依赖性(肌源性张力[MT])血管收缩作用。NO 诱导蛋白质的翻译后修饰,如 S-亚硝化(半胱氨酸残基的氧化还原修饰)。在培养细胞中,S-亚硝化降低 AngII 与 AT 受体的亲和力。本研究评估了 S-亚硝化对 AngII 依赖性和非依赖性脑血管反应的功能影响。
通过用 NO 供体 S-亚硝基谷胱甘肽(GSNO)或硝普钠(SNP)预处理,在大鼠离体大脑中动脉中诱导 S-亚硝化。通过获得 AngII 的浓度-反应曲线来评估 AT 受体激动剂依赖性激活。通过在存在或不存在选择性 AT 受体反向激动剂的情况下,在 20 至 200 mmHg 的压力范围内计算 MT(主动与被动直径),评估 AT 受体的配体非依赖性激活。
GSNO 或 SNP 完全消除了 AngII 依赖性 AT 受体介导的脑血管收缩。GSNO 对其他血管收缩剂(如苯肾上腺素、U46619)或不共享(5-HT)相同信号通路的反应没有影响。GSNO 降低了 MT,并且加入氯沙坦没有进一步降低 MT,表明 GSNO 阻断了 AT 受体依赖性 MT。抗坏血酸(可还原 S-亚硝化化合物)恢复了对 AngII 的反应,但不恢复可溶性 GC 抑制剂 ODQ 的反应,表明这些作用是通过 S-亚硝化而不是 S-亚硝化为介导。
在大鼠大脑中动脉中,GSNO 预处理特异性影响 AT 受体并降低 AngII 依赖性和非依赖性激活,这很可能是通过 AT 受体 S-亚硝化介导的。